About Us

Align CRO is a Dallas-based contract research organization specializing in phase I-II oncology research services for emerging biotech companies. Established in 2006 as a complement to the charitable mission of Mary Crowley Cancer Research, “To expand treatment options for all cancer patients through the development of molecular therapies”; the CRO has proven to be an instrumental partner in shepherding emerging cancer technologies from bench to bedside. Align CRO serves the ultimate goal of expediting clinical research and driving promising investigational agents toward FDA approval.

Align CRO prides itself in developing collaborative relationships with sponsors, and supporting a patient-centric approach for the advancement of medical science and quality execution of clinical research. This is accomplished via the ability to evaluate trial logistics during study start up and to identify key issues in need of close management through the conduct of the trial. This approach has proven to be beneficial for emerging biotech companies.

The central focus of this CRO business model is aligning science, site(s), and services with a solution oriented approach. Align CRO uniquely serves the needs of emerging biotech partners, allowing for a seamless experience in early phase drug development.

 
 

Advantages of Choosing Align CRO

Align CRO has existing partnerships with small biotech companies and provides a number of advantages, including the following:

Accessibility of personnel

  • With a targeted focus in a specialized market, Align CRO provides the highest level of partnership with clients; providing access to personnel on an ongoing basis and when urgent issues arise.

Knowledge of systems

  • Align CRO becomes familiar with a Sponsor’s systems and personnel, thus producing more effective collaboration within the existing system and organization.

Priority of the project

  • Align CRO has the ability to prioritize all projects while providing the highest level of customer service; employing Project Managers experienced in managing early phase oncology trials.

Experience / Success in Data Management

  • Align CRO has experience in database build and testing along with Data Managers who provide ongoing database oversight.

Reasonable Costs

  • Budgets are based on reasonable costs due to the alignment with Mary Crowley Cancer Research and its charitable mission.